Patients with COVID-19 had increased risk for acute MI and ischemic stroke at 14 d vs. matched controls

Lawrence Kanner1, Aaron E Glatt2

  • 1Mount Sinai South Nassau, Oceanside, New York, USA (L.K.).

Insights

COVID-19 infection increases the risk of acute myocardial infarction and ischemic stroke, particularly in the initial weeks post-diagnosis. These cardiovascular risks persist for months, highlighting the long-term impact of SARS-CoV-2 infection.

Area of Science:

  • Cardiovascular epidemiology
  • Infectious disease outcomes
  • Public health research

Background:

  • The COVID-19 pandemic has raised concerns about potential long-term cardiovascular complications.
  • Understanding the acute and sustained risks of major adverse cardiovascular events after SARS-CoV-2 infection is crucial for patient management and public health strategies.

Purpose of the Study:

  • To investigate the association between COVID-19 and the subsequent risk of acute myocardial infarction (AMI) and ischemic stroke (IS).
  • To quantify the temporal risk patterns of AMI and IS following SARS-CoV-2 infection.

Main Methods:

  • A self-controlled case series (SCCS) design was employed using Swedish national registers.
  • Matched cohort analysis was also conducted to compare individuals with and without COVID-19.
  • The study included a large cohort of individuals diagnosed with COVID-19.

Main Results:

  • A significantly elevated risk of AMI and IS was observed in the weeks immediately following a COVID-19 diagnosis.
  • The risk remained elevated for several months, although it gradually decreased over time.
  • The highest risk was noted within the first month post-infection for both outcomes.

Conclusions:

  • COVID-19 is associated with a substantial short-term and medium-term increased risk of acute myocardial infarction and ischemic stroke.
  • These findings underscore the importance of cardiovascular monitoring in patients recovering from COVID-19.
  • Public health interventions should consider the cardiovascular sequelae of SARS-CoV-2 infection.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
41
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
47
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
111
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
30
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
41
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
77